Skip to main content

Relias Media has upgraded our site!

Please bear with us as we work through some issues in order to provide you with a better experience.

Thank you for your patience.

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

July 1, 2016

View Archives Issues

  • Research: Using Generic Drugs Could Lead to Billions in Savings

    If therapeutic substitution of a generic within the same class had been used instead of the branded equivalent, $73 billion could have been saved, including nearly $25 billion in out-of-pocket expenditures for patients.

  • FDA Actions

    In this section: FDA approves a subdermal buprenorphine implant for maintenance treatment of opioid dependence; warns health professionals against using ketoconazole for the treatment of skin and nail fungal infection; investigates a possible link between canagliflozin and an increase in leg and foot amputations; advises against using fluoroquinolones for common infections; and green lights daclizumab for the treatment of relapsing multiple sclerosis.